Combined classical cytogenetics and microarray-based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Combined classical cytogenetics and microarray-based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinoma

Published:2010 Issue: Volume: Page:NA-NA
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Pei Jianming,Feder Madelyn M.,Al-Saleem Tahseen,Liu Zemin,Liu Angen,Hudes Gary R.,Uzzo Robert G.,Testa Joseph R.

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference17 articles.

1. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney;Beroukhim;Cancer Res,2009

2. Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile;Cifola;Mol Cancer,2008

3. Mutations of the VHL tumour suppressor gene in renal carcinoma;Gnarra;Nat Genet,1994

4. A comparison of DNA copy number profiling platforms;Greshock;Cancer Res,2007

5. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: Gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis;Gunawan;Cancer Res,2001

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinoma;Cancer Biology & Therapy;2020-03-01

2. Application of Chromosome Microarray Analysis for the Differential Diagnosis of Low-grade Renal Cell Carcinoma With Clear Cell and Papillary Features;Applied Immunohistochemistry & Molecular Morphology;2020-02

3. Overview of Molecular Testing of Cytology Specimens;Acta Cytologica;2019-03-27

4. The correlation between gain of chromosome 8q and survival in patients with clear and papillary renal cell carcinoma;Therapeutic Advances in Urology;2017-10-31

5. Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma;Molecular Cancer Research;2017-02-27